PCIA
TDOC icon

Prime Capital Investment Advisors’s Teladoc Health TDOC Stock Holding History

Prime Capital Investment Advisors’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-239
Closed -$48K – 502
2020
Q4 		$48K Buy
239
+67
+39% +$13.6K ﹤0.01% 327
2020
Q3 		$38K Buy
172
+37
+27% +$7.83K ﹤0.01% 338
2020
Q2 		$26K Sell
135
-104
-44% -$18.2K ﹤0.01% 372
2020
Q1 		$37K Buy
+239
New +$27.8K ﹤0.01% 302

Other funds holding TDOC

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
GCGM
General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
DVF
Discovery Value Fund Singapore $34.7M AUM 58.56% 1-Year Est. Return

Prime Capital Investment Advisors's TDOC Position: Q1 2021 in Review

Prime Capital Investment Advisors sold out of Teladoc Health (TDOC) in Q1 2021, closing a stake of 239 shares — an estimated $48K sold.

Prime Capital Investment Advisors first reported a position in TDOC in Q1 2020 and held it in 4 quarters. The position peaked at $48K in Q4 2020. 890 funds tracked by Wall St. Rank hold TDOC as of Q1 2021.

  • Prime Capital Investment Advisors reported no remaining Teladoc Health position as of Q1 2021 after selling out during the quarter.
  • Prime Capital Investment Advisors sold 239 Teladoc Health shares in Q1 2021, an estimated $48K.
  • Prime Capital Investment Advisors first reported a position in Teladoc Health in Q1 2020 and held it in 4 quarters.
  • Prime Capital Investment Advisors's Teladoc Health position peaked at $48K in Q4 2020.
  • 890 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2021.

Based on Prime Capital Investment Advisors's 13F filing for Q1 2021, filed 7 May 2021.